CARGO THERAPEUTICS IN

CARGO Therapeutics to Participate in Upcoming Investor Conferences

05 Nov 2024 15:05:00 By Nasdaq GlobeNewswire

CARGO Therapeutics Announces ASH 2024 Abstract on CRG-023, a Tri-specific CAR T, Highlighting Innovative Construct Design and Durable Anti-B-Cell Lymphoma Activity

05 Nov 2024 08:23:06 By Nasdaq GlobeNewswire

CARGO Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

12 Aug 2024 15:05:00 By Nasdaq GlobeNewswire

CARGO Therapeutics Announces Phase 1 Clinical Study of Firi-cel CAR T-Cell Therapy Published in The Lancet

10 Jul 2024 07:00:00 By Nasdaq GlobeNewswire

CARGO Therapeutics Adds Experienced Biopharma Executive to Board of Directors with the Appointment of Jane Pritchett Henderson as Independent Director

04 Jun 2024 15:05:00 By Nasdaq GlobeNewswire

CARGO Therapeutics to Participate in Upcoming Investor Conferences

28 May 2024 07:05:00 By Nasdaq GlobeNewswire

CARGO Therapeutics Announces $110.0 Million Private Placement Equity Financing

28 May 2024 07:00:00 By Nasdaq GlobeNewswire

CARGO Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

14 May 2024 15:05:00 By Nasdaq GlobeNewswire

CARGO Therapeutics Names Kapil Dhingra, M.B.B.S., to Board of Directors

15 Apr 2024 15:05:00 By Nasdaq GlobeNewswire

CARGO Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

21 Mar 2024 15:05:47 By Nasdaq GlobeNewswire

CARGO Therapeutics to Participate in the 44th Annual Cowen Healthcare Conference

29 Feb 2024 15:01:51 By Nasdaq GlobeNewswire

CARGO Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference

03 Jan 2024 07:05:03 By Nasdaq GlobeNewswire

CARGO Therapeutics Reports Business Updates and Third Quarter 2023 Results

13 Dec 2023 15:05:36 By Nasdaq GlobeNewswire